|
We are building a portfolio of compounds that have first-in-class and best-in-class potential through our own discovery research and clinical development initiatives.
more >
|
 |
02/04/10
Exelixis Announces February 9 Webcast of Presentation at the 12th
Annual BioCEO and Investor Conference
12/09/09
Exelixis Announces January 12 Webcast of Presentation at the 28th
Annual J.P. Morgan Healthcare Conference
|
|
Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference.
more >
One abstract featuring Exelixis' XL184 was presented at the meeting from October 22-24, 2009.
more >
02/09/2010 - 08:30 AM
Exelixis at Biotechnology Industry Organization CEO & Investor Conference
|
|
Looking for a career at Exelixis? We are looking for people to join us as we turn our vision into reality.
more >
NASDAQ: EXEL
Feb 9 2010 4:00PM
PRICE: 6.42 +0.32
VOLUME: 743335 SHARES
20 minute delay
more >
|
